Literature DB >> 18452068

Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia.

Aaron D Viny1, Alan Lichtin, Brad Pohlman, Thomas Loughran, Jaroslaw Maciejewski.   

Abstract

T cell large granular lymphocyte leukemia (T-LGL) is characterised by semiautonomous proliferation of monoclonal cytotoxic T lymphocytes, which can result in neutropenia, splenomegaly, and is associated with various autoimmune disorders, particularly rheumatoid arthritis. The coexistence of T-LGL leukemia with B cell abnormalities has previously been identified in case reports. However, no systematic analysis to determine the frequency of this co-association has been reported. Analysis of 63 T-LGL patients revealed a frequent association with humoral immune system abnormalities. We identified coexisting B cell dyscrasias in 17 T-LGL patients (27% of total), of whom 12 had monoclonal gammopathy of unknown significance (MGUS) (19%), and 5 had chronic lymphocytic leukemia (CLL) (8%). The presence of both MGUS and CLL was found in 2 patients (3%) and follicular lymphoma was identified with MGUS in another T-LGL patient (2%). Additionally, polyclonal hypergammaglobulinemia or hypogammaglobulinemia was found in 10 additional LGL leukemia patients bringing the total frequency of B cell abnormalities in T-LGL leukemia to 43% in our cohort. The co-association of B cell pathology with T-LGL suggests that either a common antigen drives clonal B and T cells, or that humoral malignancy could serve as the stimulus for lymphocyte expansion representing an overactive anti-tumour surveillance.

Entities:  

Mesh:

Year:  2008        PMID: 18452068     DOI: 10.1080/10428190801932635

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  23 in total

1.  Monoclonal B-cell lymphocytosis (MBL, CD4+/CD8 weak T-cell large granular lymphocytic leukemia (T-LGL leukemia) and monoclonal gammopathy of unknown significance (MGUS): molecular and flow cytometry characterization of three concomitant hematological disorders.

Authors:  Daniel Mazza Matos; Ana Cesarina Vitoriano de Oliveira; Maria de Nazaré Amaral Tomé; Carlos Alberto Scrideli
Journal:  Med Oncol       Date:  2012-06-12       Impact factor: 3.064

2.  Array comparative genomic hybridization detects chromosomal abnormalities in hematological cancers that are not detected by conventional cytogenetics.

Authors:  Lina Shao; Sung-Hae L Kang; Jian Li; Patricia Hixson; Jesalyn Taylor; Svetlana A Yatsenko; Chad A Shaw; Aleksandar Milosavljevic; Chung-Che Chang; Sau Wai Cheung; Ankita Patel
Journal:  J Mol Diagn       Date:  2010-08-19       Impact factor: 5.568

3.  Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.

Authors:  Adam W Mailloux; Ling Zhang; Lynn Moscinski; John M Bennett; Lili Yang; Sean J Yoder; Gregory Bloom; Cody Wei; Sheng Wei; Lubomir Sokol; Thomas P Loughran; Pearlie K Epling-Burnette
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

4.  Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia.

Authors:  Vivek Subbiah; Aaron D Viny; Steven Rosenblatt; Brad Pohlman; Alan Lichtin; Jaroslaw P Maciejewski
Journal:  Exp Hematol       Date:  2008-06-11       Impact factor: 3.084

5.  Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia.

Authors:  Michael J Clemente; Marcin W Wlodarski; Hideki Makishima; Aaron D Viny; Isabell Bretschneider; Mohammad Shaik; Nelli Bejanyan; Alan E Lichtin; Eric D Hsi; Eric D His; Ronald L Paquette; Thomas P Loughran; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2011-08-24       Impact factor: 22.113

6.  T-cell large granular lymphocytic leukemia and plasma cell disorders.

Authors:  M Hasib Sidiqi; Mohammed A Aljama; David S Viswanatha; David Dingli
Journal:  Haematologica       Date:  2018-09-20       Impact factor: 9.941

Review 7.  Chronic neutropenia in LGL leukemia and rheumatoid arthritis.

Authors:  Tal Gazitt; Thomas P Loughran
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 8.  Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia.

Authors:  HeeJin Cheon; Karolina H Dziewulska; Katharine B Moosic; Kristine C Olson; Alejandro A Gru; David J Feith; Thomas P Loughran
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 3.952

9.  New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2008-09       Impact factor: 0.196

Review 10.  The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.

Authors:  Ranran Zhang; Mithun Vinod Shah; Thomas P Loughran
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.